Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    -10.00 (-0.43%)
Bid:
2,320.00
Ask:
2,325.00
Spread: 5.00 (0.216%)
Market Cap: £3.15b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

6 Feb 2025 07:00

RNS Number : 0878W
RIT Capital Partners PLC
06 February 2025
 

RIT Capital Partners PLC (LEI: P31Q1NLTW35JJGHA4667)

6 February 2025

December 2024 Preliminary Unaudited Net Asset Value

RIT's preliminary, unaudited diluted NAV at 31 December 2024 (with debt at fair value) was 2,614p per £1 ordinary share (30 November 2024: 2,635p). The NAV per share return for the month decreased -0.8%, compared to the MSCI ACWI (50% £) which declined -1.2%.

The preliminary 31 December 2024 NAV is equivalent to a NAV per share total return for the year of 9.4%, with positive returns across all three investment pillars. Our annualised NAV per share total return since inception is 10.5%, underscoring our commitment to delivering healthy, long-term returns for our shareholders.

As is customary at this point in our year-end process, the preliminary NAV and associated performance numbers for 2024 are estimates, and subject to potential adjustment and audit. Full details will be included in the 2024 Annual Report and Accounts, which is expected to be published by early March.

December Performance Highlights

In December, our performance saw a decline in Quoted Equities and Uncorrelated Strategies, which were partially offset by gains in Private Investments and positive currency translation effects.

·

In Quoted Equities, US cyclicals reversed some of the post-US election gains, while healthcare stocks saw headwinds from a higher interest rate environment and more uncertain policy outlook. These were partially offset by positive performances from SMID cap stocks and investments with managers in Japan.

·

Private Investments rose in value after an uplift in December valuations of our direct holdings. As of 31 December, more than 99% of our private funds were held at 30 September reported valuations and all private direct holdings were valued at 31 December, in line with our valuation policy.

·

Uncorrelated Strategies detracted from our NAV, with mark-to-market losses in our UK gilts as government bond yields soared to multi-decade highs.

·

Currency acted as a modest contributor, primarily due to the US dollar's appreciation against sterling.

·

We continued our ongoing share buyback programme in December. During the year, we repurchased £80 million or approximately 4.3 million shares.

 

 

 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

 

Deutsche Numis (Joint broker):

David Benda

T: 020 7260 1000

 

JP Morgan Cazenove (Joint broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Sofie Brewis

T: 020 7404 5959

E: RIT@BrunswickGroup.com 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVVELFBELLEBBZ
Date   Source Headline
12th Apr 20197:00 amRNSNet Asset Value(s)
3rd Apr 20193:59 pmRNSQUARTERLY DISCLOSURE - Listing Rule 15.6.8
22nd Mar 20194:01 pmRNSDirector/PDMR Shareholding
14th Mar 20197:00 amRNSNet Asset Value(s)
5th Mar 20197:00 amRNSAnnual Financial Report
18th Feb 20197:00 amRNSNet Asset Value(s)
5th Feb 20197:00 amRNSNet Asset Value(s)
8th Jan 201910:02 amRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Dec 20187:00 amRNSNet Asset Value(s)
30th Nov 201810:53 amRNSComposition of Board Committee
14th Nov 20187:00 amRNSNet Asset Value(s)
29th Oct 20184:59 pmRNSComposition of Board Committee
16th Oct 201811:11 amRNSDirector Declaration
12th Oct 20187:00 amRNSNet Asset Value(s)
5th Oct 20185:03 pmRNSDirector/PDMR Shareholding
4th Oct 20185:46 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Sep 20187:00 amRNSNet Asset Value(s)
24th Aug 20183:15 pmRNSAppointment of Joint Broker
14th Aug 20187:00 amRNSNet Asset Value(s)
7th Aug 20187:00 amRNSHalf-year Report
18th Jul 20187:00 amRNSNet Asset Value(s)
3rd Jul 20186:00 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Jun 20187:00 amRNSNet Asset Value(s)
15th May 20187:00 amRNSNet Asset Value(s)
26th Apr 201812:41 pmRNSDirectorate Change
26th Apr 201812:27 pmRNSResult of AGM
16th Apr 20187:25 amRNSNet Asset Value(s)
6th Apr 20185:54 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
28th Mar 20185:09 pmRNSDirector/PDMR Shareholding
26th Mar 201811:54 amRNSDirectorate Change
14th Mar 20187:00 amRNSNet Asset Value(s)
5th Mar 20186:00 pmRNSDirector/PDMR Shareholding
27th Feb 20187:00 amRNSFinal Results and Dividend
14th Feb 20187:00 amRNSNet Asset Value(s)
5th Feb 201810:02 amRNSInitiation research from QuotedData
31st Jan 20187:00 amRNSNet Asset Value(s)
22nd Dec 201710:08 amRNSDirector/PDMR Shareholding
22nd Dec 20177:00 amRNSDirectorate Change
20th Dec 20174:17 pmRNSDirector Declaration
14th Dec 20177:00 amRNSNet Asset Value(s)
27th Nov 20175:54 pmRNSDirector/PDMR Shareholding
16th Nov 20175:28 pmRNSComposition of Board Committee
14th Nov 20177:00 amRNSNet Asset Value(s)
19th Oct 20174:19 pmRNSDirectorate Change
16th Oct 20177:00 amRNSNet Asset Value(s)
14th Sep 20177:00 amRNSNet Asset Value(s)
14th Aug 20177:00 amRNSNet Asset Value(s)
14th Aug 20177:00 amRNSHalf-year Report
21st Jul 201710:00 amRNSDirectorate Change
18th Jul 20177:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.